ArticleThoracic cancer2023

Efficacy and safety of cyclin-dependent kinase 4/6 inhibitor in patients with advanced breast cancer: A real-world experience.

Tzu-Rong Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.